NASA will hold a media teleconference at 3 p.m. EDT on Monday, April 18, to discuss the status of the next wet dress rehearsal test of the agency’s Space Launch System (SLS) rocket and Orion spacecraft at Launch Complex 39B at the agency’s Kennedy Space Center in Florida ahead of the uncrewed Artemis I lunar mission.
Due to upgrades required at an off-site supplier of gaseous nitrogen used for the test, NASA will take advantage of the opportunity to roll SLS and Orion back to the Vehicle Assembly Building to replace a faulty upper stage check valve and a small leak on the tail service mast umbilical. During that time, the agency also will review schedules and options to demonstrate propellant loading operations ahead of launch.
The teleconference will stream live on the agency’s website.
Teleconference participants include:
- Tom Whitmeyer, deputy associate administrator for common exploration systems development, NASA Headquarters in Washington
- Charlie Blackwell-Thompson, Artemis launch director, NASA Exploration Ground Systems program, Kennedy
- Mike Sarafin, Artemis mission manager, NASA Headquarters
To participate by telephone, media must RSVP no later than two hours prior to the start of the event to: ksc-newsroom@mail.nasa.gov.
Through Artemis missions, NASA will land the first woman and the first person of color on the Moon, paving the way for a long-term lunar presence and serving as a steppingstone to send astronauts to Mars.
For updates, follow along on NASA’s Artemis blog at:
https://blogs.nasa.gov/artemis
- FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder
Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds). Today’s action marks the first FDA approval of a treatment for EoE. “As researchers and clinicians have gained knowledge about eosinophilic… Read more: FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder - New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace
Today, the U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications. The FDA wants consumers who use dietary supplements to know that today’s draft… Read more: New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace - NASA, Partners Offer Global View of Environmental Changes
Continuing the collaboration that produced the COVID-19 Earth Observing Dashboard in 2020, NASA and its international partners in Europe and Japan have combined the collective scientific power of their Earth-observing satellite data in expanding the online resource to document a broad array of planet-wide changes in the environment and human society. The expanded dashboard from… Read more: <strong>NASA, Partners Offer Global View of Environmental Changes</strong> - SPACEX LAUNCHED ANOTHER STARLINK MISSION
On Wednesday, May 18 at 6:59 a.m. ET, SpaceX launched 53 Starlink satellites from Launch Complex 39A (LC-39A) at Kennedy Space Center in Florida. This was the fifth flight for the Falcon 9 first stage booster supporting this mission, which previously launched Arabsat-6A, STP-2, COSMO-SkyMed Second Generation FM2, and now two Starlink missions. - Dine Outdoors with Delicious Plant-Forward Dishes
(Family Features) As rays of sunshine light up backyards and patios, many families take their meals outdoors to enjoy the warm weather while sharing special moments together. More time spent eating meals on the deck or patio calls for recipes that fit your al fresco theme from plant-forward takes on traditional summer fare to platters… Read more: Dine Outdoors with Delicious Plant-Forward Dishes
